\begin{tabular}{lcccccc}
   \hline
 
         \multicolumn{1}{l}{Mock} & \multicolumn{1}{c}{No. cases /}   & \multicolumn{2}{c}{HR per 10-fold incr.}                     & \multicolumn{1}{c}{P-value}   & \multicolumn{1}{c}{q-value}   & \multicolumn{1}{c}{FWER} \\ 
         \multicolumn{1}{l}{Immunologic Marker}            & \multicolumn{1}{c}{No. at-risk**} & \multicolumn{1}{c}{Pt. Est.} & \multicolumn{1}{c}{95\% CI} & \multicolumn{1}{c}{(2-sided)} & \multicolumn{1}{c}{} & \multicolumn{1}{c}{} \\ 
         \hline
 
    Spike IgG (IU/ml) & 71/13,295 & 0.09 & (0.05-0.14) & $<$0.001 & $<$0.001 & $<$0.001 \\ 
  RBD IgG (IU/ml) & 71/13,295 & 0.25 & (0.19-0.33) & $<$0.001 & $<$0.001 & $<$0.001 \\ 
  PsV-nAb ID50 & 71/13,295 & 0.31 & (0.23-0.41) & $<$0.001 & $<$0.001 & $<$0.001 \\ 
  PsV-nAb ID80 & 71/13,295 & 0.33 & (0.26-0.43) & $<$0.001 & $<$0.001 & $<$0.001 \\ 
   \hline
\end{tabular}
